In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

S Laukkanen, T Grönroos, P Pölönen, H Kuusanmäki, J Mehtonen, J Cloos, G Ossenkoppele, B Gjertsen, B Øystein, C Heckman, M Heinäniemi, M Kontro, O Lohi

    Research output: Contribution to journalArticleScientificpeer-review

    23 Citations (Scopus)
    Original languageEnglish
    Article numbere604
    Pages (from-to)e604
    JournalBlood Cancer Journal
    Volume7
    Issue number9
    DOIs
    Publication statusPublished - 2017
    Publication typeA1 Journal article-refereed

    Publication forum classification

    • Publication forum level 1

    Cite this